Updated on March 16, 2021 at 8:08 am
NBC Universal, Inc.
Uterine fibroids that can cause chronic pain and disrupt pregnancy plans disproportionately affect Black women, and research that would help women and girls is underfunded, experts say.
The noncancerous tumors can be as small as a pea to larger than a football. More than 80% of Black women will have fibroids by age 50, the National Institutes of Health says, compared to about 70% of white women. Black women with fibroids are twice as likely as white women to have hysterectomies as a treatment.
Download our NBC DFW mobile app for Apple or Android to get alerts for local breaking news and weather.
Fibroids Are 3x More Likely to Affect Black Women, and Research Funding Is Low nbcmiami.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcmiami.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ROCHESTER, N.Y., Feb. 19, 2021 /PRNewswire/ Vuzix® Corporation (NASDAQ: VUZI), ( Vuzix or, the Company ), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that the Company s Vuzix M400 Smart Glasses were featured in the American Medical Association s Special COVID-19 Edition for Accelerating Change in Medical Health Education Systems Science Student, Resident and Fellow Impact Challenge. The clinical study was conducted by the University of Louisville School of Medicine and summarized in the recent publication by the American Medical Association.
Shadowing and preceptorship opportunities allow students to get an early idea of what specialty they would like to pursue. The pandemic made it impossible for students around the country to safely get the desired exposure to patients and practicing physicians; making personal decisions regarding their specialty they would plan to pursu
As Johns Hopkins’ Chief Diversity Officer, Golden realized few weeks into the pandemic that Black, Indigenous and Hispanic Americans were disproportionately affected by COVID-19.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Microbot Medical Enhances Scientific Advisory Board with World Renowned Interventional Radiologists
Microbot MedicalJanuary 21, 2021 GMT
HINGHAM, Mass., Jan. 21, 2021 (GLOBE NEWSWIRE) Microbot Medical Inc. (Nasdaq: MBOT) continues to enhance its thought leadership capabilities with the addition of several new Scientific Advisory Board (SAB) members: Stephen B. Solomon, MD, a board-certified radiologist with clinical expertise in Interventional Radiology with a focus in Tumor Ablation; Ajay K. Wakhloo, MD PhD FAHA, an internationally recognized expert in acute stroke therapy and the isolation of intracranial aneurysms and arteriovenous malformations; Gal Yaniv, MD, PhD, an endovascular neurosurgeon and leading authority on Artificial Intelligence; Dmitry J. Rabkin, MD, PhD, FSIR, a vascular and Interventional Radiology Specialist; and Ziv Neeman, MD, a vascular and interventional radiol